title: Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial?
authors.forename: O
authors.initials: O
authors.lastname: Landgren
authors.forename: H
authors.initials: H
authors.lastname: Andrén
authors.forename: B
authors.initials: B
authors.lastname: Nilsson
authors.forename: A
authors.initials: A
authors.lastname: Ekbom
authors.forename: M
authors.initials: M
authors.lastname: Björkholm
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015992:Body Mass Index; D002423:Cause of Death; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009765:Obesity / Q000175:diagnosis* / Q000401:mortality; D011379:Prognosis; D012016:Reference Values; D012042:Registries; D012189:Retrospective Studies; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome